Germany’s new supply chain due diligence law (LkSG, or Lieferkettengesetz in its short form) came into force on 1 January for companies with more than 3,000 employees. This group numbers some 600 companies, according to the federal ministry for labour and social affairs, BMAS. A further 3,000 firms – those employing over 1,000 staff – will be subject to enforcement in January 2024.
Small and medium-sized enterprises (SMEs) manufacturing or distributing medtech will be affected indirectly, insomuch as they trade with companies – and even hospitals – over the size thresholds. The LkSG...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?